| 000 | 01642 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250516235231.0 | ||
| 264 | 0 | _c20141222 | |
| 008 | 201412s 0 0 eng d | ||
| 022 | _a1556-9519 | ||
| 024 | 7 |
_a10.3109/15563650.2014.965827 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSt-Onge, M | |
| 245 | 0 | 0 |
_aTreatment for calcium channel blocker poisoning: a systematic review. _h[electronic resource] |
| 260 |
_bClinical toxicology (Philadelphia, Pa.) _cNov 2014 |
||
| 300 |
_a926-44 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review; Systematic Review | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aCalcium Channel Blockers _xblood |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 |
_aDrug Overdose _xmortality |
| 650 | 0 | 4 | _aGuidelines as Topic |
| 650 | 0 | 4 | _aHospitalization |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInsulin _xtherapeutic use |
| 650 | 0 | 4 | _aLength of Stay |
| 650 | 0 | 4 | _aObservational Studies as Topic |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 |
_aVasoconstrictor Agents _xadministration & dosage |
| 700 | 1 | _aDubé, P-A | |
| 700 | 1 | _aGosselin, S | |
| 700 | 1 | _aGuimont, C | |
| 700 | 1 | _aGodwin, J | |
| 700 | 1 | _aArchambault, P M | |
| 700 | 1 | _aChauny, J-M | |
| 700 | 1 | _aFrenette, A J | |
| 700 | 1 | _aDarveau, M | |
| 700 | 1 | _aLe Sage, N | |
| 700 | 1 | _aPoitras, J | |
| 700 | 1 | _aProvencher, J | |
| 700 | 1 | _aJuurlink, D N | |
| 700 | 1 | _aBlais, R | |
| 773 | 0 |
_tClinical toxicology (Philadelphia, Pa.) _gvol. 52 _gno. 9 _gp. 926-44 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.3109/15563650.2014.965827 _zAvailable from publisher's website |
| 999 |
_c24248871 _d24248871 |
||